NCT04107168 2023-02-16Microbiome Immunotherapy Toxicity and Response EvaluationCambridge University Hospitals NHS Foundation TrustUnknown1,800 enrolled
NCT00873236 2013-08-12MRI Scans of Blood Vessel Changes Caused by Bevacizumab Alone or Given Together With Interferon Alpha-2a in Treating Patients With Stage III or Stage IV Kidney CancerNational Cancer Institute (NCI)Phase 2 Unknown30 enrolled